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Abstract: Binding of the competitive inhibitor L-captopril to the dapEencoded N-succinyl-L,L-diaminopimelic acid desuccinylase from Neisseria
meningitidis (NmDapE) was examined by kinetic, spectroscopic, and
crystallographic methods. L-Captopril, an angiotensin-converting enzyme
(ACE) inhibitor, was previously shown to be a potent inhibitor of the DapE
from Haemophilus influenzae (HiDapE) with an IC50 of 3.3 μM and a measured
Ki of 1.8 μM and displayed a dose-responsive antibiotic activity toward
Escherichia coli. L-Captopril is also a competitive inhibitor of NmDapE with a
Ki of 2.8 μM. To examine the nature of the interaction of L-captopril with the
dinuclear active site of DapE, we have obtained electron paramagnetic
resonance (EPR) and magnetic circular dichroism (MCD) data for the
enzymatically hyperactive Co(II)-substituted forms of both HiDapE and
NmDapE. EPR and MCD data indicate that the two Co(II) ions in DapE are
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antiferromagnetically coupled, yielding an S = 0 ground state, and suggest a
thiolate bridge between the two metal ions. Verification of a thiolate-bridged
dinuclear complex was obtained by determining the three-dimensional X-ray
crystal structure of NmDapE in complex with L-captopril at 1.8 Å resolution.
Combination of these data provides new insights into binding of L-captopril to
the active site of DapE enzymes as well as important inhibitor-active site
residue interaction’s. Such information is critical for the design of new, potent
inhibitors of DapE enzymes.

Graphical abstract

Several pathogenic bacteria, some of which were thought to
have been eradicated, have made a significant resurgence because of
bacterial resistance to antibiotics.1,2 According to the Centers for
Disease Control and Prevention, several bacterial strains currently
exhibit multidrug resistance, with >60% of hospital-acquired infections
in the United States caused by the so-called ESKAPE pathogens
(Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae,
Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter
species).3 To alleviate the problem of antibiotic resistance, it is
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important that new enzymatic targets be identified and specific
inhibitors developed.4 The meso-diaminopimelate (mDAP)/lysine biosynthetic pathway offers several potential antibacterial enzyme
targets, such as the dapE-encoded N-succinyl-L,L-diaminopimelic acid
desuccinylase (DapE).5–7 The products of this pathway, mDAP and
lysine, are essential components of the peptidoglycan cell wall for
Gram-negative and most Gram-positive bacteria, providing a link
between polysaccharide strands.6,8,9 DapE genes have been identified
in a large number of pathogenic Gram-positive and Gram-negative
bacteria, including all of the ESKAPE pathogens.10–16 Sequence
alignment of these DapE genes reveals a minimum of 49% sequence
identity. Deletion of the gene encoding DapE is lethal to Helicobacter
pylori and Mycobacterium smegmatis even in the presence of lysinesupplemented media.10,17 Therefore, DapEs are essential for bacterial
cell growth and, as there are no similar biosynthetic pathways in
mammals, are targets for inhibitors that may possess antimicrobial
activity.5
DapEs are metalloenzymes that catalyze the hydrolysis of Nsuccinyl-L,L-diaminopimelic acid (SDAP), forming L,L-diaminopimelic
acid and succinate.8 DapEs have been purified from multiple sources,
but the best characterized example is the DapE from Haemophilus
influenzae (HiDapE), which is a homodimeric enzyme (subunit Mr =
41.6 kDa) that requires two Zn(II) ions per mole of polypeptide for full
enzymatic activity.13 The X-ray crystal structures for both mono- and
dinuclear Zn(II) forms of HiDapE [Zn_(HiDapE) and ZnZn(HiDapE)]
have been reported previously.16 In the dinuclear Zn(II) form, each
Zn(II) ion adopts a distorted tetrahedral geometry coordinated by one
imidazole (H67 for Zn1 and H349 for Zn2) and one carboxylate group
(E163 for Zn1 and E135 for Zn2). Both Zn(II) ions are bridged by an
additional carboxylate group (D100) and a water/hydroxide, forming a
(μ-aquo)(μ-carboxylato)dizinc(II) core with a 3.3 Å Zn–Zn distance.16
To date, no X-ray crystallographic data for a DapE–inhibitor complex
have been reported.
Thiols are commonly used as inhibitors of Zn(II) metalloproteins
because Zn(II) is a relatively soft acid and thiols are soft bases.18
Examination of several thiol-based compounds led to the identification
of moderately strong inhibitors of HiDapE.14,19 For example, Lpenicillamine exhibits an IC50 value of 13.7 μM toward HiDapE and is a
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competitive inhibitor with a measured Ki of 4.6 μM. DapE is also
stereoselective with respect to the recognition of substrate and
inhibitors, as D-penicillamine provided an IC50 value of 50 μM.14
Similarly, L-captopril, an angiotensin-converting enzyme (ACE)
inhibitor, exhibited an IC50 value of 3.3 μM toward HiDapE, while Dcaptopril yielded an IC50 value of 42 μM. L-Captopril was shown to be a
competitive inhibitor of HiDapE with a measured Ki of 1.8 μM and
displayed a dose-responsive antibiotic activity toward Escherichia
coli.14 Even though L-captopril is a moderately tight binding inhibitor of
DapE enzymes and is a promising lead compound for the development
of a novel class of DapE inhibitors, no information about how Lcaptopril binds to DapE, a requirement for the rational design of new,
more potent DapE inhibitors, has been published.
A likely important characteristic of a highly specific, tight binding
inhibitor of DapE enzymes will be the molecule’s ability to bind to the
metal ions in the active site. Several factors are important for
interactions of L-captopril with the active site metal ions of DapE,
some of which are metal coordination geometry, open metal
coordination sites (i.e., those filled by water molecules), and the
number of active site metal ions. Therefore, we have analyzed the
binding of L-captopril to HiDapE and the DapE from Neisseria
meningitidis (NmDapE) via kinetic and spectroscopic methods. We
have also determined the X-ray crystal structure of the NmDapE
enzyme in complex with L-captopril at 1.8 Å resolution. These data
provide insight into interactions of L-captopril with the active site
metal ions as well as adjacent active site amino acid residues,
providing new insight into the rational design of new, more potent
inhibitors of DapE enzymes.

Methods
Materials
D,L-α,ɛ-Diaminopimelic acid (98%), succinic anhydride, and ionexchange resin (Dowex 50WX8-200, H+ form) were purchased from
Sigma. 2-Naphthalenesulfonic acid 1-hydrate (98%) was purchased
from TCI, and microcrystalline cellulose was purchased from Merck. All
other chemicals were purchased from commercial sources and were of
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the highest quality available. SDAP was synthesized using the
procedure described by Lin et al.,20 providing an overall yield of 41%.

Cloning, Expression, and Purification of DapE
The HiDapE enzyme was expressed and purified as described
previously.21 The DapE gene from N. meningitidis (NmDapE) was
cloned into the pMCSG7 vector using the ligation-independent cloning
method.22 The following primers were used: 5′-TAC TTC CAA TCC AAT
GCC GCA GCT GCA GCT GCA AAA GAA AAA GTG GTT TCG TTG GCA
CAA G-3′ and 5′-TTA TCC ACT TCC AAT GTT AGT TAG CTA TCC AAT
AAA TTC ACT AAC ATT TTG TG-3′. The PCR product was purified using
the QIAquick PCR Purification Kit (Qiagen) to remove the primers and
dNTPs from the PCR mixture. T4 polymerase was employed to create
overhangs on the PCR fragments. The resulting plasmid was
transformed into BL21(DE3)/magic E. coli competent cells and grown
in Luria-Bertani broth containing ampicillin (150 μg mL−1) and
kanamycin (25 μg mL−1) at 37 °C to an A600 of 1.0 while being shaken.
IPTG was added (0.4 mM), and culture growth was continued for 16 h
at 18 °C. Cells were recovered by centrifugation (12000g) for 15 min
at 4 °C using a Beckman Coulter Avanti J-E Centrifuge. NmDapE was
purified according to the standard protocol for Ni-NTA affinity
chromatography, and all steps were performed at 4 °C.23 The His6 tag
was removed by treating each enzyme with His6-tagged TEV protease
for 16 h at 4 °C in 50 mM HEPES (pH 8.0). Cleaved protein was
separated from His6-tagged TEV using Ni-NTA affinity chromatography.

Enzymatic Assay
The specific activity of HiDapE and NmDapE was determined
using a 50/50 mixture of D,D- and L,L-SDAP as the substrate in 50
mM phosphate buffer (PPi) (pH 7.5) as previously described.24 The
kinetic parameters Vmax and Km were determined by quantifying amide
bond cleavage (decrease in absorbance) of L,L-SDAP at 225 nm (ɛ =
698 M−1 cm−1) in triplicate using a Shimadzu UV-2450
spectrophotometer equipped with a temperature controller (25 °C).
Enzyme activities are expressed as units per milligram, where 1 unit is
defined as the amount of enzyme that releases 1 μmol of L,L-SDAP at
30 °C in 1 min. Catalytic activities were determined with an error of
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±10%. Initial rates were fit directly to the Michaelis–Menten equation
to obtain the catalytic constants Km and kcat using Origin software.

Inhibition of NmDapE by L-Captopril
The kinetic parameters v (velocity), kcat (Vmax/[E]0), Km
(Michaelis constant), and Ki (inhibition constant) were determined in
50 mM phosphate buffer (pH 7.5) spectrophotometrically by recording
the initial velocity of the hydrolysis of L,L-SDAP at 25 °C in triplicate.14
L-Captopril concentrations ranged from 0 to 0.1 mM. The linearity of
the progress curves for product formation in the absence and presence
of an inhibitor indicated that L-captopril is in rapid equilibrium with
NmDapE. The initial rates were plotted against substrate
concentration, and the kinetic constants were calculated using Origin
software.20,24,25

Co(II)-Substituted DapE Samples
Apo-DapE was prepared by extensive dialysis for 72 h at 4 °C
against 10 mM EDTA in 50 mM HEPES buffer (pH 7.5). DapE was then
exhaustively dialyzed against metal-free (Chelex-100 treated) 50 mM
HEPES buffer (pH 7.5). Any remaining metal ions were estimated by
comparing the activity of the apoenzyme with that of a sample that
had been reconstituted with Zn(II). DapE incubated with EDTA
typically had <5% residual activity after dialysis. The mono- and
dicobalt(II) forms of HiDapE and NmDapE were prepared using apoDapE samples that were incubated with CoCl2 (99.999%; Strem
Chemicals, New-buryport, MA) for 30 min at 25 °C prior to exhaustive
dialysis into Chelex-100-treated buffer as previously reported.26

Electron Paramagnetic Resonance Spectroscopy
Electron paramagnetic resonance (EPR) spectra were recorded
at 4.5–35 K and 9.63 GHz (ER4116DM resonator with B0⊥B1), 9.37
GHz (ER4116DM resonator with B0‖B1), or 9.39 GHz (SHQ resonator)
using 1.2 mT (12 G) magnetic-field modulation at 100 kHz with phasesensitive detection on a Bruker EleXsys E600 spectrometer equipped
with an Oxford Instruments ESR900 helium flow cryostat and ITC503
temperature controller. The SHQ resonator has a B1 for a given
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microwave power significantly higher than that of the ER4116DM
resonator (we estimate by a factor of ~5). Background signals were
collected on samples of frozen buffer and subtracted.

Magnetic Circular Dichroism Studies
The magnetic circular dichroism (MCD) instrument consists of a
JASCO J815 spectropolarimeter and an Oxford Instruments SM4000
cryostat/magnet. Variable-temperature variable-field (VTVH) MCD data
were collected in increments of 0.5 T (T) from 0 to 7.0 T and at
temperatures (nominally) of 1.5, 3.0, 6.0, 12, 24, and 48 K. Spectra
were collected at a 1.0 nm bandwidth and scanned at 50 nm/min using
a time constant of 1 s. The sample cell has a 0.62 cm path length.
Each spectrum was corrected for any natural CD by subtracting the
zero-field spectrum of the sample. Even when there is no sample
present, the instrument baseline exhibits a small deviation from zero
that is both field- and wavelength-dependent. Therefore, each
spectrum was also corrected by subtraction of a spectrum recorded at
the same magnetic field but with no sample present. The MCD spectra
were fit to the minimal number of Gaussian peaks using Grams AI 9.1
after converting the spectra to wavenumber units. In the fitting
process, a minimal number of Gaussians were fit to achieve a
satisfactory composite spectrum. Fitting of the VTVH MCD data was
achieved using a Fortran program, VTVH 2.1.1, written by M. Riley.27
The spin Hamiltonian and additional details of the fitting program have
been described previously.28 The fits were tested for robustness once a
complete set of parameters had been obtained. To do this, the initial
parameters were set to the best-fit parameters and then all allowed to
float. Subsequently, one key parameter such as J, D, Mxy, Mxz, or Myz
was chosen, and its initial value was set differently, after which the fit
process was repeated. Percent polarization for a given fit was
calculated from Mxy, Myz, and Mxz using %Mx = (Mxy × Myz)2/[(Mxy ×
Mxz) + (Mxy × Myz)2 + (Mxz × Myz)2]. My and Mz were calculated
correspondingly.29 Finally, the VTVH MCD data fitting program used a
spin Hamiltonian that included the term H = −2JS1S2.
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Protein Crystallization
Prior to crystallization, a 25 mg/mL NmDapE protein sample was
incubated with 3 equiv of Zn(II) ions and left on ice for 20 min to
equilibrate. Zinc(II)-loaded NmDapE was screened against 300
commercially available conditions (Index HT and PEG/Ion HT from
Hampton Research and Wizard TM from Emerald Biosystems) using a
Mosquito liquid handling robot with 96 plates.30 Several crystallization
conditions were characterized yielding diffraction quality crystals. All
crystals were screened, and data were collected on the best-diffracting
crystals, which were grown by the sitting-drop vapor-diffusion method
at 16 °C using 400 nL of a precipitant solution [20% (w/v) PEG 3350
and 100 mM HEPES (pH 7.5)] and 400 nL of [ZnZn(NmDapE)]. X-ray
quality crystals appeared within 2 weeks. Crystals of [Zn_NmDapE]
were also crystallized by the sitting-drop vapor-diffusion method at
16 °C but with a 400 nL precipitant solution [15% (w/v) PEG 3350 and
100 mM succinic acid (pH 7.0)] and 400 nL of a protein, providing
crystals within 2 weeks. Crystals of [ZnZn(NmDapE)] in complex with
L-captopril were obtained by mixing 400 nL of a precipitant solution
[0.2 M ammonium acetate, 0.1 M TRIS (pH 8.5), and 25% (w/v)
polyethylene glycol 3350] in a 1:1 ratio with a solution of
[ZnZn(NmDapE)] incubated with a 30 mM solution of L-captopril [50
mM HEPES (pH 7.5) and 150 mM NaCl] with crystals appearing within
3 weeks.

Structure Solutions and Refinement
The X-ray data were collected at beamline 19-ID of the
Structural Biology Center at the Advanced Photon Source.31 All data
were processed and scaled using HKL3000.32 Molecular replacement
searches were completed with MOLREP within the CCP4 suite using the
structure of apo-NmDapE as a template [Protein Data Bank (PDB)
entry 1VGY].16 The asymmetric unit of [Zn_(NmDapE)] (space group
P212121) contains a dimer, while crystals of [ZnZn(NmDapE)] and
[ZnZn(NmDapE)] in complex with L-captopril both crystallized in the
C2221 space group and contained only one subunit of the dimer in the
asymmetric unit. Several rounds of rebuilding and readjusting using
COOT33 and refinement using REFMAC34 and PHENIX35 improved the
initial models. The final models were refined against 95% of the
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reflections within the resolution ranges. The remaining 5% of the
reflections, which were randomly selected, were used to monitor Rfree.
The final refinement statistics are listed in Table 1. Analysis and
validation of all structures were performed with the aid of PROCHECK36
and MOLPROBITY.37 The refinement restraints for the L-captopril
structure were created with the assistance of COOT and were
generated from SMILE string.38
Table 1. Data and Refinement Statistics
[Zn_NmDapE] [ZnZn_NmDapE] [ZnZn_NmDapE]-Lcaptopril
Data Collection
space group unit cell (Å) P212121

C2221

C2221

a = 55.3

a = 117

a = 116.9

b = 111.4

b = 151.6

b = 151.5

c = 132.5

c = 55.5

c = 55.1

resolution (Å)

39.2–2.09

29.4–2.0

27.5–1.78

wavelength (Å)

0.98

0.98

0.98

no. of observed
reflections

204709

202836

178375

no. of unique reflections

48738

33502

46112

redundancyb

4.2 (4.0)

6.1 (5.8)

3.9 (3.8)

Rmergea,b (%)

7.4 (82.1)

8.5 (89.9)

6.5 (75.2)

Rpim

4.0 (45.7)

4.3 (59.4)

3.3 (44.2)

completenessb (%)

99.1 (96.7)

100 (100)

97.7 (99.5)

I/σ

17.9 (1.5)

22.8 (1.9)

17.7 (1.7)

MR

MR

MR

a,b

(%)

phasing
phasing method

Refinement
Rcryst (%)

21.3

17.5

16.4

Rfree (%)

24.1

20.8

19.6

no. of protein residues

746

374

374

no. of
zinc/phosphate/sulfate
ions

3/–/4

2/1/–

2/–/1

no. of solvent molecules

380

237

284

bond lengths (Å)

0.003

0.020

0.021

bond angles (deg)

0.71

1.69

1.90

protein

43.8

32.2

24.8

Zn

32.0

23.2

17.9

H2O

37.8

24.19

34.6

rmsd from target values

average B factor

(Å2)
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[Zn_NmDapE] [ZnZn_NmDapE] [ZnZn_NmDapE]-Lcaptopril
PDB entry

4O23

4PPZ

4PQA

Ramachandran (%)c
97.4/2.6
97.6/2/4
97.9/2.1
MF/AA
aR
merge = ΣhklΣi|Ii(hkl) − ⟨Ihkl⟩|/ΣhklΣiIi(hkl), where Ii(hkl) is the ith observation of reflection
hkl and ⟨Ihkl⟩ is the weighted average intensity for all observations i of reflection hkl.
Rpim=∑hkl[1/(N−1)1/2]∑i∣∣Ii(hkl)−¯I¯hkl∣∣/∑hkl∑iIi(hkl).
bNumbers in parentheses are values for the highest-resolution bin.
cAs defined by MOLPROBITY (MF, most favored, AA, additionally allowed).

PDB Coordinates
The atomic coordinates for [Zn_(NmDapE)], [ZnZn(NmDapE)],
and [ZnZn(NmDapE)] bound by L-captopril were deposited in the PDB
as entries 4O23, 4PPZ, and 4PQA, respectively.

Results
Kinetic Studies of [Zn_(NmDapE)] and [ZnZn(NmDapE)]
Steady-state kinetic parameters for the hydrolysis of L,L-SDAP
by [Zn_(NmDapE)] and [ZnZn(NmDapE)] and [Zn_(HiDapE)] and
[ZnZn(HiDapE)] are listed in Table 2. The kinetic parameters obtained
for Zn(II)-loaded NmDapE are very similar to those previously
reported for Zn(II)-loaded HiDapE.14 Of note is the lack of dependence
of Km on the zinc content, while the dizinc forms exhibit almost twice
the catalytic efficiency of the monozinc forms. L-Captopril was found to
be a competitive inhibitor of [ZnZn(NmDapE)] with a Ki of 2.8 μM, a
value similar to that observed for [ZnZn(HiDapE)] (Ki of 1.8 μM).
Table 2. Kinetic Constants for [Zn_(DapE)] and [ZnZn(DapE)] from N.
meningitidis and H. influenza
NmDapE

HiDapE

Zn

ZnZn

Zn

ZnZn

Km (μM)

795 ± 20

610 ± 11

730 ± 15

730 ± 15

kcat (s−1)

76 ± 10

120 ± 10

80 ± 5

140 ± 10

5700 ± 200

11800 ± 200

6600 ± 200

11400 ± 200

kcat/Km

(mM−1

min−1)
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EPR Spectra of L-Captopril Bound to [Co_(NmDapE)],
[CoCo(NmDapE)], [Co_(HiDapE)], and [CoCo(HiDapE)]
EPR spectra of the resting forms of Co(II)-substituted NmDapE
(Figure 1A) and HiDapE (Figure 1B) reveal clear similarities. At 13 K
and a nonsaturating microwave power, the [Co_(DapE)] spectra
(traces A in panels A and B of Figure 1) are complex and appear to be
due to a moderately rhombic (E/D ≤ 0.15) MS = ±½ signal with
resonances at g′ = 5.35 (1250 G), 4.05 (1660 G), and 2.25 (3015 G),
superimposed on an MS = ±3/2 signal with a sharp resonance at g′ =
6.5 (1030 G) and a broad derivative feature with an estimated turning
point at g′ ≈ 1.15. At 4.5 K and a high microwave power (traces B in
panels A and B of Figure 1), the MS = ±½ signals are almost
completely extinguished. This latter behavior indicates that the MS =
±½ signals are due to thermal population of the MS = ±½ Kramers’
doublet at a higher temperature associated with an excited state with
a zero-field splitting, Δ, on the order of 10 cm−1 for [Co_(NmDapE)],
and less for [Co_(HiDapE)], where some MS = ±½ contribution is still
evident at 4.5 K (1 cm−1 corresponds to 1.44 K). If the MS = ±½
signals were ground-state signals due to a distinct chemical species,
rapid-passage signals would be expected rather than disappearance or
diminution of the signals.39 These data indicate a preferred binding site
with an MS = ±3/2 ground state, suggesting a distorted tetrahedral
coordination environment.39
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Figure 1. (A) EPR spectra at 9.39 GHz (SHQ resonator) of [Co_(NmDapE)] (A and B)
and [CoCo(NmDapE)] (C and D), recorded at 13 K and 0.5 mW (A and C) and 4.5 K
and 100 mW (B and D). Spectral amplitudes are shown normalized for 1/T,
(Pmicrowave)1/2, and the number of equivalents of Co(II) added. (B) EPR spectra at 9.39
GHz (SHQ resonator) of [Co_(HiDapE)] (A and B) and [CoCo(HiDapE)] (C and D),
recorded at 13 K and 1.0 mW (A and C) and 4.5 K and 200 mW (B and D). Spectral
amplitudes are shown normalized for 1/T, (Pmicrowave)1/2, and the number of equivalents
of Co(II) added.
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Upon addition of a second equivalent of Co(II), a poorly
resolved and apparent MS = ±½ signal was observed at 13 K (traces C
in panels A and B of Figure 1). In addition, a very weak but clearly
identifiable 59Co hyperfine pattern with Az = 90 G was observed on the
low-field edge of the MS = ±½ signal, centered at g′ = 7.9 (850 G;
see, e.g., Figure 1A, trace C), but is not clearly visible at the scale
used in panels A and B of Figure 1. This hyperfine signal could be due
to a small amount of an additional MS = ±3/2 signal with greal(z) ~ 2.6
or else a very rhombic (E/D ~ 1/3) MS = ±½ signal with greal(y) ~2.9;
the origin of the hyperfine split signal is unclear, but it was completely
insensitive to L-captopril and was not considered further.
In contrast to the case for [Co_(NmDapE)] and [Co_(HiDapE)],
when EPR spectra of [CoCo(NmDapE)] and [CoCo(HiDapE)] were
recorded at 4.5 K, the predominant MS = ±½ signal was clearly still
observable as a rapid-passage signal that appeared as an inverted
absorption-shaped feature, superimposed on the sharp MS = ±3/2
signal at g′ = 6.5 (traces D in panels A and B of Figure 1). The
appearance of a slowly relaxing ground-state MS = ±½ signal is
consistent with the second added equivalent of Co(II) occupying a
five- or six-coordinate site. There is a slight difference between the
signals from [CoCo(NmDapE)] and [CoCo(HiDapE)]. The signal from
[CoCo(NmDapE)] appears to account for the entire complement of
Co(II), whereas that from [CoCo(HiDapE)] indicates that some EPR
silent Co(II) is present. Further, the MS = ±3/2 signal in
[CoCo(HiDapE)] is significantly smaller than in [Co_(HiDapE)] (traces
D and B, respectively, in Figure 1B), whereas this is not the case in
[CoCo(NmDapE)] (traces D and B, respectively, in Figure 1A; note that
in both panels A and B of Figure 1, traces D have been multiplied by
0.5 relative to traces B to account for 2 vs 1 equiv of Co2+). These data
suggest a weak antiferromagnetic interaction between the Co(II) ions
in [CoCo(HiDapE)], such that |J| > hν for some, but not all, of the
population of dinuclear centers in the sample, i.e., that there is a
distribution of J that includes 0.3 cm−1. No parallel mode (B0‖B1) EPR
signals were observed.
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Addition of L-captopril induced differential effects in
[CoCo(NmDapE)] and [CoCo(HiDapE)]
Addition of L-captopril to [CoCo(NmDapE)] resulted in the sharp
MS =±3/2 signal at g′ = 6.5 being essentially extinguished, but no
overall signal intensity was lost (Figure 2, traces A and B). This is
consistent with additional coordination to the hitherto four-coordinate
Co(II) ion but no mediation of significant (≥0.3 cm−1) exchange
coupling between the two Co(II) ions. In contrast, the addition of Lcaptopril to [CoCo(HiDapE)] leads to a wholesale loss of ~30% of the
EPR intensity, with no detectable change in line shape (Figure 2, traces
C and D), signifying an increase, albeit modest, in the level of
exchange coupling between the two Co(II) ions.

Figure 2. EPR spectra at 9.63 GHz (ER4116DM resonator) of [CoCo(NmDapE)] before
(A) and after (B) the addition of L-captopril and [CoCo(HiDapE)] before (C) and after
(D) the addition of L-captopril. Spectra were recorded at 4.5 K and 100 mW. Spectral
amplitudes are shown normalized for 1/T, (Pmicrowave)1/2, and the number of equivalents
of Co(II) added.
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MCD Spectra of L-Captopril Bound to [Co_(NmDapE)],
[CoCo(NmDapE)], [Co_(HiDapE)], and [CoCo(HiDapE)]
MCD spectra of [CoCo(NmDapE)] and [CoCo(HiDapE)] are
nearly identical in shape, band energy, and intensity (Figure 3). It
should be noted that the MCD spectra obtained at ambient
temperature in the absence of a glycerol glassing agent have the same
bands as the low-temperature spectra; however, they are much less
intense and broader. All of the bands display temperature-dependent
C-terms arising from the paramagnetic high-spin Co(II) ground states.
The intense negative band at 576 nm is asymmetric because of a small
component at 559 nm in [CoCo(HiDapE)] and at 558 nm in
[CoCo(NmDapE)]. This intense negative band along with an intense
positive band at 532 nm is characteristic of high-spin Co(II) in a
distorted tetrahedral ligand field.40–42 These bands arise from the 4A2 →
4
T1(P) d−d transition in Td that has been split into three components by
the lowe-symmetry environment in the active site. The negative band
at 503 nm along with a very weak positive band at shorter
wavelengths is characteristic of high-spin Co(II) in a distorted
octahedral ligand field.40,41,43,44 The band at 503 nm arises from the
4
T1g → 4T1g(P) d–d transition in Oh that can broaden or split at lower
symmetries. The 503 nm band does not split in [CoCo(NmDapE)] or
[CoCo-(HiDapE)] but is noticeably broader in [CoCo(HiDapE)] than in
[CoCo(NmDapE)]. The very weak positive bands at 463 and 475 nm in
[CoCo(HiDapE)] and [CoCo(NmDapE)], respectively, are doublet
transitions, which gain intensity through spin–orbit coupling to the
nearby spin-allowed 503 nm band.43 Despite the similarity in the MCD
spectra of [CoCo(HiDapE)] and [CoCo(NmDapE)], there is a difference
in the relative metal binding affinities between the two enzymes. When
1 equiv of Co(II) is added to apo-NmDapE, both the six-coordinate and
four-coordinate sites are partially occupied (Figure SI-1 of the
Supporting Information). Addition of a second equivalent of Co(II)
saturates both binding sites. On the other hand, addition of 1 equiv of
Co(II) to apo-HiDapE saturates the four-coordinate site, leaving the
six-coordinate site virtually empty (Figure SI-2 of the Supporting
Information).
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Figure 3. MCD spectra of (A) [CoCo(HiDapE)] (top) and [CoCo(NmDapE)] (bottom)
and (B) [CoCo(HiDapE)] with 5 equiv of L-captopril (top) and [CoCo(NmDapE)] with 5
equiv of L-captopril (bottom). All spectra were recorded at 1.3 K and 7.0 T in a 0.62
cm path length cell. The enzymes were in a 60/40 (v/v) glycerol/buffer solution.
[CoCo(HiDapE)] at 32 mg/mL [0.77 mM enzyme, 1.6 mM in active sites, 3.1 mM in
Co(II)]. [CoCo(NmDapE)] at 29 mg/mL [0.70 mM enzyme, 1.4 mM in active sites, 2.8
mM in Co(II)]. The units of Δɛ/H are M−1 cm−1 T−1, where the concentration of active
sites was used. In both panels, the blue trace is the experimental spectrum and the
red traces are the Gaussians used to fit the spectra.
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VTVH MCD data were collected at 503, 532, and 576 nm on
both [CoCo(NmDapE)] and [CoCo(HiDapE)]. These data were used to
construct magnetization plots; typical examples are shown in Figures
SI-3–SI-8 of the Supporting Information. The VTVH MCD data were fit
as previously described,27 which yielded the electronic ground-state
parameters for magnetic exchange coupling (J) and axial (D) and
rhombic (E) zero-field splitting (ZFS). Typical fits are also shown in
Figures SI-3–SI-8 of the Supporting Information. Multiple experiments
were run, and average values of these parameters along with the
standard deviations are given in Table 3. Magnetic exchange coupling,
if it occurs, will be strongest through monatomic bridges (e.g., μ-1,1
as opposed to μ-1,3). In none of the fittings of the VTVH data from
[CoCo(NmDapE)] or [CoCo(HiDapE)] was the quality of the fit
improved (lower value of χ2) by having a nonzero J (positive or
negative). This strongly suggests that the bridging oxygen atom is in
the form of a μ-aqua as opposed to a μ-hydroxo. Many dicobalt(II)
complexes with either a μ-aqua or μ-hydroxo have been studied.8,44–46
Aqua-bridged complexes consistently exhibit a small antiferromagnetic
coupling (negative J) or no coupling at all, whereas hydroxo-bridged
complexes consistently have a small ferromagnetic (positive J)
coupling. In addition to the previously reported dicobalt(II) complexes,
three new model complexes that are consistent with this trend are
shown in Figures SI-13 and SI-14 of the Supporting Information. The
ZFS parameters that were determined in the fitting of the VTVH data
from [CoCo-(NmDapE)] and [CoCo(HiDapE)] were also consistent with
assignment of the 503 nm band to a six-coordinate Co(II), and the
532 and 576 nm bands to a distorted four-coordinate Co(II).
Generally, the axial ZFS parameter, D, is >50 cm−1 for six-coordinate
high-spin Co(II) and <10 cm−1 for four-coordinate high-spin Co(II).8,42
Table 3. VTVH MCD Fitting Parameters
parameter [CoCo(NmDapE)]a

[CoCo(NmDapE)]
and captoprilb

[CoCo(HiDapE)]c

[CoCo(HiDapE)]
and captoprild

J (cm−1)

0

−0.1

0

−0.05 ± 0.04

D (cm−1),
4C

3.7 ± 0.6

0.05

3.7 ± 1.0

4.1 ± 1.5

E/D, 4C

~0

0.002

~0

0.25 ± 0.14

D (cm−1),
6C

>100

>50

>100

28 ± 5

E/D, 6C

0.18 ± 0.04

~0

0.27 ± 0.04

0.08 ± 0.03

505 nm na

503 nm x-pol.

505 nm z-pol.

530 nm na

532 nm xy-pol.

530 nm z-pol.

polarization 503 nm x-pol.
532 nm xy-pol.
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parameter [CoCo(NmDapE)]a
576 nm xy-pol.

[CoCo(NmDapE)]
and captoprilb

[CoCo(HiDapE)]c

[CoCo(HiDapE)]
and captoprild

604 nm z-pol.

576 nm xy-pol.

604 nm z-pol.

aBased

on three independent experiments; ±one standard deviation.
bBased on a single experiment.
cBased on eight independent experiments.
dBased on four independent experiments.

The addition of 1 equiv (based on the concentration of active
sites) of L-captopril to either [CoCo(HiDapE)] or [CoCo-(NmDapE)] has
no apparent effect on the MCD spectra. However, addition of 5 equiv
of L-captopril causes the green resting enzyme solutions to turn blue
(Figure 3B). The four-coordinate Co(II) bands shift from 532, 559, and
576 nm in [CoCo(HiDapE)] to 530, 565, and 604 nm, respectively, in
the [CoCo(HiDapE)]–L-captopril complex, while the bands for the same
species shift from 532, 558, and 576 nm in [CoCo(NmDapE)] to 530,
565, and 604 nm, respectively, in the [CoCoNmDapE]–L-captopril
complex. The six-coordinate band at 503 nm splits into two bands at
488 and 505 nm for the [CoCo(HiDapE)]–L-captopril and
[CoCo(NmDapE)]–L-cap-topril complexes. There is a small peak at 576
nm in both spectra, which is due to uncomplexed enzyme. In addition
to these band shifts, there is a roughly 3-fold decrease in MCD
intensity, which is not due to loss of Co(II) from the enzyme caused by
L-captopril. Finally, the quality of the optical glasses formed in the
presence of L-captopril is not as high as for the resting enzyme alone.
The resulting MCD spectra had signal-to-noise ratios considerably
lower than those of the MCD spectra obtained for the resting enzymes.
VTVH MCD data were also collected on the 505, 530, and 604
nm bands in the [CoCo(HiDapE)]–L-captopril complex and only for the
604 nm band in the [CoCo(NmDapE)]–L-captopril complex. Example
magnetization plots and fits are shown in Figures SI-9–SI-12 of the
Supporting Information. The χ2 values for fits of the 505 and 530 nm
data are quite high as is the χ2 value for the 604 nm data for the
[CoCo-(NmDapE)]–L-captopril complex. The best fits were obtained
with a small negative value for J. In addition, the ZFS parameters for
both the six- and four-coordinate sites changed but were still in the
ranges expected for the corresponding Co(II) species (Table 3).
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Crystal Structures of [Zn_(NmDapE)], [ZnZn(NmDapE)], and the L-Captopril-Bound
[ZnZn(NmDapE)] Complex
The X-ray crystal structures of [Zn_(NmDapE)] (2.1 Å),
[ZnZn(NmDapE)] (2.0 Å), and the [ZnZn-(NmDapE)]–L-captopril
complex (1.8 Å) were determined. These three structures along with
that of apo-NmDapE, which was previously determined (PDB entry
1VGY),47 reveal the typical two-domain homodimer structure (either
present in the asymmetric unit or generated by the crystallographic 2fold axis) observed for all DapE enzymes. Comparison of all four
structures of NmDapE shows that the overall fold is well-preserved and
the structures of the apo, monozinc, dizinc, and L-captopril-bound
forms are nearly identical. Each of these structures overlays with an
rmsd for Cα atoms of 0.59 Å {apo-NmDapE over [Zn_(NmDapE)]} and
0.73 Å {apo-NmDapE over [ZnZn(NmDapE)] and L-captopril-bound
[ZnZn-(NmDapE)]}. Close analysis of the [ZnZn(NmDapE)] and
[ZnZn(NmDapE)]–L-captopril structures [both were determined from
isomorphous crystals grown under similar conditions (Table 1)] reveals
that inhibitor binding does not introduce any significant changes into
the structure as evidenced by a very low rmsd of 0.2 Å. Furthermore,
examination of the active site regions of the [ZnZn(NmDapE)]
structure indicates that the metal ions and ligands are in nearly
identical positions. The dinuclear Zn(II) active sites in both
[ZnZn(NmDapE)] and the [ZnZn(NmDapE)]–L-captopril complex adopt
coordination geometries identical to that reported for HiDapE.16
For [ZnZn(NmDapE)], the first metal binding site, Zn1, resides
in a distorted tetrahedral geometry and is bound by the carboxylate
OD1 atom of D101 and OE1 atom of E164 as well as the NE1 atom of
H68. The Zn2 metal ion resides in a distorted trigonal bipyramidal
geometry and is bound by the NE2 atom of H350, two oxygen atoms,
OD2 from D101 and OE2 from E136, and the O1 atom of ethylene
glycol. Interestingly, for [Zn_(NmDapE)] a full dimer resides in the
asymmetric unit, and Zn(II) binding is different between the two
active sites. In one of the active sites, a single Zn(II) ion is bound in
the first metal binding site, while in the second active site, two Zn(II)
ions are present but with occupancies modeled at 60% for Zn1 and
18% for Zn2. These data suggest that metal binding is not strictly
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sequential for NmDapE, which is different from that observed for
HiDapE.
The 1.8 Å structure of the [ZnZn(NmDapE)]–L-captopril complex
reveals clear electron density corresponding to L-captopril inside the
positively charged groove, formed between the catalytic and
dimerization domains (Figure 4). The sulfhydryl group of L-captopril
bridges the two active site Zn(II) ions with Zn–S distances of 2.3 Å,
displacing the bridging water molecule. The carboxylate of the proline
moiety of L-captopril forms a hydrogen bond with N346 (ND2–O3, 3.0
Å) and the amide of G325 (N–O2, 2.9 Å). It also makes a strong
hydrogen bond with the hydroxyl of Y198 (OH–O3, 2.5 Å), which
reaches over from the second subunit of the dimer. The O1 peptide
carbonyl oxygen of L-captopril forms a hydrogen bond with a wellordered water molecule (2.8 Å) that is stabilized by its interaction with
R179 (NH2–O, 3.1 Å) and P165 (2.6 Å).
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Figure 4. Structure of the [ZnZn(NmDapE)]–L-captopril complex. (A) Ribbon diagram
of the homodimer of [ZnZn(NmDapE)] (subunit A colored orange and subunit B blue).
The Zn(II) ions in the dinuclear active site are shown as black spheres, while
molecules of L-captopril are shown as green sticks. (B) Close-up of the active site
region showing the hydrogen bonding interactions of L-captopril (green) with
surrounding protein residues and solvent molecule (red sphere). The active site
residues are color-coded (orange and blue sticks) according to the subunit coloring,
while the conserved residues binding to the Zn(II) ions are colored gray. (C)
Schematic drawing of the dinuclear Zn(II) active site bound by L-captopril (distances
in angstroms).
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Discussion
EPR spectra of [Co_(NmDapE)] and [Co_(HiDapE)] suggest the
first Co(II) ion to bind resides in a distorted tetrahedral coordination
geometry at low temperatures, and this assignment is consistent with
the crystallographic and MCD data. EPR spectra of [CoCo(NmDapE)]
and [CoCo(HiDapE)] suggest a five- or six-coordinate Co(II) ion in the
second metal binding site. The EPR data also indicate an
antiferromagnetic interaction due to the formation of a spin-coupled
species with | J| > 0.3 cm−1 between the Co(II) ions in
[CoCo(HiDapE)] but no interaction was detected in
[CoCo(NmDapE)];24 some 30% of the Co(II) in [CoCo(HiDapE)] is EPR
silent. EPR of the L-captopril complexes of both [CoCo(NmDapE)] and
[CoCo(HiDapE)] indicated that the hitherto tetrahedral Co(II) ion
acquired an additional ligand(s) and modulated the spin coupling in the
latter (Figure 2), consistent with the captopril-derived thiolate bridge
observed in the crystal structure (Figure 4). For both [CoCo(NmDapE)]
and [CoCo(HiDapE)], characteristic MCD bands for high-spin Co(II) in
a distorted tetrahedral and distorted octahedral ligand field are
observed (Figure 3), consistent with EPR data. An interesting finding is
that despite the similarity in the MCD spectra between
[CoCo(NmDapE)] and [CoCo(HiDapE)], the spectra obtained for
[CoCo(NmDapE)] reveal that both the four- and six-coordinate sites
are occupied upon the addition of only 1 equiv of Co(II), suggesting a
less than strictly sequential binding model for NmDapE that is not
observed for HiDapE. This finding is consistent with EPR data as well
as the X-ray crystal structure of [Zn_(NmDapE)].
Correlation of the ZFS observed by MCD with coordination
number was used as a coordination number indicator (termed the
CN/ZFS correlation). In the CN/ZFS correlation, four- coordinate Co(II)
exhibits ZFS < 13 cm−1, also observed directly here by EPR; fivecoordinate between 20 and 50 cm−1; and six-coordinate above 50
cm−1.48 The ZFS parameters determined from fits of VTVH data for
[CoCoNmDapE] and [CoCoHiDapE] are consistent with four-coordinate
and six-coordinate Co(II) centers in the active site. On the basis of
previously published magnetic properties of several μ-aqua μ-hydroxo
dicobalt(II) model complexes, weak to moderately strong
antiferromagnetic coupling would be expected from a single oxygen
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atom bridge.49,50 Fitting of the VTVH data from [CoCoNmDapE] and
[CoCoHiDapE] strongly suggests that the bridging oxygen atom, in the
resting enzyme, is due to μ-aqua as opposed to μ-hydroxo moieties.
MCD data of the L-captopril complexes are consistent with the thiol of
L-captopril bridging the two active site Co(II) ions, producing an
antiferromagnetically coupled dicobalt(II) center with an S = 0 ground
state. The overall changes strongly suggest that L-captopril displaces
the bridging water molecule and binds to both metal ions through a
monatomic bridge whose ligand-field strength is less than that of
water. These findings are consistent with EPR data for [CoCoHiDapE]
bound by L-captopril. Taken together, the optical, magneto-optical,
and EPR results are in strong agreement and indicate that L-captopril
interacts directly with both metal ions.
Additional structural information was obtained from X-ray
crystallography, including the finding that no active site ligands are
displaced upon L-captopril binding except for replacement of the water
molecule that bridges the two Zn(II) ions in the wild-type enzyme by
the L-captopril-derived thiolate sulfur atom. The remainder of the
molecular structure of DapE is barely perturbed, but some significant
hydrogen bonds to L-captopril that likely identify residues important
for substrate and inhibitor recognition and/or binding are formed. The
binding of L-captopril to the dinuclear active site of [ZnZn-(NmDapE)]
provides the first structural data for an inhibited form of any DapE
enzyme, providing a model for inhibitor design as well as enzyme–
substrate interactions.
Inspection of the X-ray crystal structures of [Zn_(NmDapE)] and
[ZnZn(NmDapE)], combined with surface analysis, reveals a deep
groove that extends along the borders of the catalytic and dimerization
domains and houses the active site. This well-defined and negatively
charged cavity is shaped from the top by strand β17 and α10 and in
the middle by the loop connecting these two elements (residues 321–
328). The bottom of the cavity is formed by a loop (residues 132–142)
connecting β-strands β6 and α5 and a loop (residues 341–355)
connecting β18 and β19. Because the substrate has a linear shape, we
predict that it binds in an extended conformation, lining up along the
groove with the peptide bond positioned right over the active site
metals. DapE enzymes have strict specificity for the L,L-isoform of
SDAP.24 This specificity is built into the active site that includes both
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the dinuclear metal cluster and adjacent amino acid residues that form
a substrate binding cavity groove. Several studies indicate that
substrate binding pockets play an important role in substrate
recognition and binding for metallohydrolases.51–53 Insight into the role
of this cavity comes from the structure of the [ZnZn(NmDapE)]-Lcaptopril complex as several interactions between the inhibitor and
residues within this cavity are formed. The L-captopril peptide bond
forms a hydrogen bond with a well-ordered water molecule, which is
stabilized by R179 and P165. In addition, the carboxyl terminus of the
dipeptide is held in position by ionic interactions between N346 and
G325. Interestingly, the carboxyl group also forms a hydrogen bond
with the hydroxyl moiety of Y198, which resides on the other subunit
of the dimer. This interaction is of great interest, because it is the first
evidence of a residue from the second subunit interacting with an
inhibitor bound to the first subunit. These data suggest a heretofore
unknown function for dimer formation of DapE enzymes. Specifically,
this indicates that the dimerization domain not only is crucial for dimer
formation but also could play an important role in substrate
recognition and binding. This is consistent with the findings that
dimerization domain deletion mutants of HiDapE are inactive,
highlighting the importance of DapE dimer formation.16
In summary, a major limitation in developing a previously
undescribed class of antimicrobials that target DapE enzymes has been
the lack of knowledge about binding of the inhibitor to the DapE active
site, including potential residues involved in substrate recognition and
binding. We have spectroscopically and crystallographically
characterized the binding of the competitive inhibitor L-captopril to
DapE. The thiol moiety of L-captopril coordinates to both active site
metal ions in a μ-thiolate fashion. No other inhibitor-centered ligands
interact with the active site metal ions. Analysis of the first X-ray
crystal structure of a DapE enzyme bound to an exogenous ligand, the
[ZnZn(NmDapE)]–L-captopril complex, allowed for identification of
several important active site pocket residues. These include R179,
P165, and N346 that form hydrogen bonds to the functional groups of
L-captopril. Remarkably, Y198 from one subunit was discovered to be
involved in hydrogen bond formation with the L-captopril bound to the
active site of the opposite subunit. This unforeseen hydrogen bonding
interaction may be critical for catalysis and may also prove to be
crucial in the development of novel medicinal chemistry leads. Because
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L-captopril is an angiotensin-converting enzyme (ACE) inhibitor and a
moderately strong inhibitor of DapE enzymes, understanding the
electronic and structural properties of binding of L-captopril to the
active site of DapE provides a foundation for the design of new, more
potent DapE inhibitors.
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Figure SI-1. MCD spectra of NmDapE with 1 and 2 eq. of added Co2+. The enzyme
concentration was 29 mg/mL in 60/40 (v/v) glycerol/buffer (0.70 mM in protein, 1.4 mM in
active sites). The spectra were recorded at 1.5 K and 7.0 T in a 0.63 cm path length cell. The
MCD peaks due to four-coordinate (4-C) and six-coordinate (6-C) Co2+ are indicated. The
binding affinities of both sites appear to be nearly equal.
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Figure SI-2. MCD spectra of HiDapE with 1 and 2 eq. of added Co2+. The enzyme concentration
was 33 mg/mL in 60/40 (v/v) glycerol/buffer (0.80 mM in protein, 1.6 mM in active sites). The
spectra were recorded at 1.5 K and 7.0 T in a 0.63 cm path length cell. The MCD peaks due to
four-coordinate (4-C) and six-coordinate (6-C) Co2+ are indicated. The binding affinity of the
four-coordinate site appears to be much higher than the six-coordinate site.
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Figure SI-3. Magnetization plot of the VTVH MCD data collected on the 503 nm band in
CoCoNmDapE. Key ground state electronic parameters are given in the figure and are typical for
six-coordinate high-spin Co2+.
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Figure SI-4. Magnetization plot of the VTVH MCD data collected on the 503 nm band in
CoCoHiDapE. Key ground state electronic parameters are given in the figure and are typical for
six-coordinate high-spin Co2+.
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Figure SI-5. Magnetization plot of the VTVH MCD data collected on the 532 nm band in
CoCoNmDapE. Key ground state electronic parameters are given in the figure and are typical for
four-coordinate high-spin Co2+.
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Figure SI-6. Magnetization plot of the VTVH MCD data collected on the 532 nm band in
CoCoHiDapE. Key ground state electronic parameters are given in the figure and are typical for
four-coordinate high-spin Co2+.

CoCoHiDapE 532 nm

Normalized Intensity

1
0.8
0.6

J=0
0.4

-1

D = 4.9 cm
E/D = 0
xy-polarized

0.2

2

χ = 0.02
0

0

0.4

0.8

1.2

Exp 1.5 K
Fit 1.5 K
Exp 3.0 K
Fit 3.0 K
Exp 6.0 K
Fit 6.0 K
Exp 12 K
Fit 12 K
Exp 24 K
Fit 24 K
Exp 48 K
Fit 48 K

1.6

βH/2kT

7

Figure SI-7. Magnetization plot of the VTVH MCD data collected on the 576 nm band in
CoCoNmDapE. Key ground state electronic parameters are given in the figure and are typical for
four-coordinate high-spin Co2+.
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Figure SI-8. Magnetization plot of the VTVH MCD data collected on the 576 nm band in
CoCoHiDapE. Key ground state electronic parameters are given in the figure and are typical for
four-coordinate high-spin Co2+.
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Figure SI-9. Magnetization plot of the VTVH MCD data collected on the 505 nm band in
CoCoHiDapE with 5 eq. of captopril. Key ground state electronic parameters are given in the
figure and are typical for four-coordinate high-spin Co2+.

CoCoHiDapE + Captopril 505 nm

Normalized Intensity

1
0.8
0.6

J = -0.03 cm
D = 28 cm

exp 1.3K
fit 1.3 K
exp 3 K
fit 3 K
exp 4.2 K
fit 4.2 K
exp 10 K
fit 10 K

-1

-1

1

E /D = 0.11

0.4

1

1

D = 3.9 cm

-1

2

E /D = 0.33
2

0.2

2

z-polarized
2

χ = 0.6

0

0

0.5

1

1.5

2

βH/2kT

10

Figure SI-10. Magnetization plot of the VTVH MCD data collected on the 530 nm band in
CoCoHiDapE with 5 eq. of captopril. Key ground state electronic parameters are given in the
figure and are typical for four-coordinate high-spin Co2+.
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Figure SI-11. Magnetization plot of the VTVH MCD data collected on the 604 nm band in
CoCoNmDapE with 5 eq. of captopril. Key ground state electronic parameters are given in the
figure and are typical for four-coordinate high-spin Co2+.
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Figure SI-12. Magnetization plot of the VTVH MCD data collected on the 604 nm band in
CoCoHiDapE with 5 eq. of captopril. Key ground state electronic parameters are given in the
figure and are typical for four-coordinate high-spin Co2+.

CoCoHiDapE + Captopril 604 nm

Normalized Intensity

1
0.8

exp 1.3 K
fit 1.3 K
exp 3 K
fit 3 K
exp 4.2 K
fit 4.2 K
exp 10 K
fit 10 K
exp 25 K
fit 25 K
exp 50 K
fit 50 K

-1

J = -0.04 cm

-1

D = 6.3 cm

0.6

1

E /D = 0.32
1

1

-1

D = 27 cm

0.4

2

E /D = 0.08
2

2

z-polarized

0.2

2

χ = 0.01
0

0

0.5

1

1.5

2

βH/2kT

13

Figure SI-13. (A) Structure of [Co2(µ-OH)(µ-1,3-CF3COO)2(Me3TACN)2]+. (B) MCD spectrum
of [Co2(µ-OH)(µ-1,3-CF3COO)2(Me3TACN)2]+ in ethanol taken at 1.3 K and 7.0 T. (C)
Magnetization plot for the 462 nm band of the complex. The complex was synthesized according
to Lachicotte, R.; Kitayforodskiy, A.; Hagen, K. S. J. Am. Chem. Soc. 1993, 115, 8883-8884.
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Figure SI-14. (A) Structure of CoF and CoH. (B) MCD spectra of CoH and CoF. The spectrum
of CoH was taken as a solid mull at 1.3 K and 7.0 T. The spectrum of CoF was taken as a 2.5
mM solution in EtOH at 1.3 K and 7.0 T. (C) Magnetization plot for the 497 nm band of CoF.
The VTVH MCD data from CoH were also fitted (not shown) and the fit parameters are: J = 0.65 cm-1, D = 64 cm-1, E/D = 0.33, y-polarized, χ2 = 0.07. CoF and CoH were synthesized
according to Lachicotte, R.; Kitayforodskiy, A.; Hagen, K. S. J. Am. Chem. Soc. 1993, 115,
8883-8884.
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